Nicholas G. Zaorsky

University Hospitals of Cleveland — United States

Medicine · Health Sciences

53h-index10.2kcitations385works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(106), Prostate Cancer Treatment and Research(98), Advanced Radiotherapy Techniques(91), Lung Cancer Treatments and Mutations(34), Lung Cancer Diagnosis and Treatment(33)

Publications384 total

Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials
Cancer·2025Open Access
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer
JAMA Oncology·2025· 2 citedOpen Access
Heart Disease Mortality After Primary Cancer Surgery in the United States
American Journal of Clinical Oncology·2025
Response to commentary on “Brachial plexopathy following stereotactic body radiation therapy in apical lung malignancies: A dosimetric pooled analysis of individual patient data” by Sawada et al.
Radiotherapy and Oncology·2025
The climate and health impact of U.S. radiation therapy: estimating greenhouse gas emissions, DALYs, and potential of hypofractionation
Radiotherapy and Oncology·2025· 2 cited
Drivers of HPV vaccination rates among adolescent dependents in the military health system
Vaccine·2025
Individual income and race-associated differences in prostate cancer mortality in a statewide registry
JNCI Cancer Spectrum·2025Open Access
Efficacy of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analysis From the International Radiosurgery Oncology Consortium of the Kidney
International Journal of Radiation Oncology*Biology*Physics·2025· 4 cited
Experimental Index Fund Investment vs. Historical NIH Grant Application Strategy to Fund Clinical Radiation Oncology Research
International Journal of Radiation Oncology*Biology*Physics·2025
Response to Sheu et al, “Comments on Fakult et al’s ‘Epidemiology of Merkel cell carcinoma in the United States’”
Journal of the American Academy of Dermatology·2025· 1 cited
Projected cumulative lifetime earnings of physicians
2025Open Access
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials
JAMA Network Open·2025· 4 citedOpen Access
The efficacy and safety of neoadjuvant and adjuvant chemo(radio)therapy combined with surgery in patients with locally advanced rectal cancer harboring defective mismatch repair system: a large-scale multicenter propensity score analysis
Frontiers in Immunology·2025· 3 citedOpen Access
Utilization, Acute Complications, and Delays in Treatment Associated With Rectal Spacers for Prostate Cancer Radiotherapy
Urology·2025Open Access
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer
European Urology Oncology·2025· 1 cited
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men
JCO Precision Oncology·2025
METANOVA: A phase II trial of metastasis-directed radiotherapy for de novo oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial.
Journal of Clinical Oncology·2025
Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of Change
JCO Oncology Practice·2025
The epidemiology of Merkel cell carcinoma in the United States
Journal of the American Academy of Dermatology·2025· 6 cited
Epidemiology of carcinomatosis
Cancer Epidemiology·2025
page 1 of 20Next →

Frequent Co-authors

Eric J. Lehrer(19), Daniel M. Trifiletti(13), Daniel E. Spratt(8), Adam P. Dicker(7), Mao-Bin Meng(6), Robert T. Dess(5), Kelsey C. Stoltzfus(5), Leila T. Tchelebi(5), Ming Wang(5), Robert B. Den(5), Huan-Huan Wang(5), Zhiyong Yuan(5), Lei Deng(4), Vernon M. Chinchilli(4), Paul L. Nguyen(4), Jennifer Peterson(4), Paul D. Brown(4), Joshua D. Palmer(4), Shankar Siva(4), Timothy N. Showalter(4)